Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| FUHS ULRICH MARTIN | Chief Accounting Officer | 7 | $0 | $0 | 2024-05-20 |
| DURAND REMY | Chief Business Officer | 20 | $0 | $0 | 2024-05-20 |
| Drappa Jorn | Director | 6 | $0 | $0 | 2024-05-20 |
| Hernday Natasha | Director | 10 | $0 | $0 | 2024-05-20 |
| Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | 12 | $0 | $0 | 2024-05-20 |
| PENG STANFORD L | See Remarks | 40 | $0 | $0 | 2024-05-20 |
| Peetz Christopher | Director | 17 | $19.3K | $19.3K | 2024-05-20 |
| Rickey James Paul | Senior VP and CFO | 72 | $49.5K | $5.84M | 2024-05-20 |
| Thompson Peter A. | Director, 10% Owner | 30 | $11.50M | $37.22M | 2024-05-20 |
| Topper James N | Director, 10% Owner | 25 | $2.00M | $1.2K | 2024-05-20 |
| GOLD MITCHELL | Executive Chairman and CEO | 85 | $1.02M | $10.14M | 2024-05-20 |
| CONWAY ROBERT E | Director | 22 | $329.5K | $151.2K | 2024-05-20 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 9 | $11.50M | $0 | 2024-05-18 |
| Cui Xiangmin | Director, 10% Owner | 14 | $19.19M | $0 | 2024-01-18 |
| OrbiMed Genesis GP LLC | Director | 6 | $0 | $28.67M | 2023-12-28 |
| Decheng Capital Global Healthcare Fund (Master), LP | 10% Owner | 1 | $4.69M | $0 | 2023-11-09 |
| Dummer Wolfgang | Chief Medical Officer | 1 | $0 | $0 | 2023-10-02 |
| Sandler Andrew Seth | Chief Medical Officer | 2 | $0 | $0 | 2023-01-05 |
| Venkatesan Jay | President | 21 | $1.02M | $3.76M | 2022-07-15 |
| FHM LIFE SCIENCES VIII, L.P. | 10% Owner | 1 | $799.9K | $0 | 2022-02-11 |
| Decheng Capital Management III (Cayman), LLC | 10% Owner | 1 | $14.50M | $0 | 2021-09-17 |
| Alpine Bioventures, GP, LLC | 10% Owner | 2 | $0 | $3.76M | 2021-09-17 |
| Goldberg Zelanna | Chief Medical Officer | 1 | $0 | $0 | 2021-06-01 |
| OrbiMed Capital GP VI LLC | Director, 10% Owner | 1 | $0 | $8.55M | 2020-12-28 |
| SEKHRI PAUL J | Director | 3 | $0 | $0 | 2020-01-02 |
| TIGER MANAGEMENT L.L.C. | 10% Owner | 1 | $0 | $146.3K | 2019-02-08 |
| Litton Mark James | See Remarks | 3 | $0 | $0 | 2019-02-06 |
| Frazier Life Sciences VIII, L.P. | 10% Owner | 2 | $2.00M | $0 | 2019-01-18 |
| Alpine ImmunoSciences, L.P. | 10% Owner | 2 | $1.02M | $0 | 2019-01-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 78,000 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 2,635 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 109,000 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 112,500 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 70,155 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 26,922 | — | $0 | 0 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 28,700 | — | $0 | 0 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 14,600 | — | $0 | 0 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | D To issuer deriv | 2024-05-20 | 2024-05-20 | 52,180 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 215,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 336,755 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 240,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 200,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 208,916 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 247,951 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 70,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 270,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer deriv | 2024-05-20 | 2024-05-20 | 255,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 42,407 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 236,623 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 71,874 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 50,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 81,088 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 142,975 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 215,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 150,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 120,000 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 112,945 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 78,000 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 137 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 143 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 1,214 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 836 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 112,500 | — | $0 | 0 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer deriv | 2024-05-20 | 2024-05-20 | 108,999 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 1,912 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 3,075 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 2,868 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 20,000 | — | $0 | 0 | SEC↗ |
| Hernday Natasha | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Hernday Natasha | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Hernday Natasha | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Hernday Natasha | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Hernday Natasha | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 15,000 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer | 2024-05-20 | 2024-05-20 | 102,192 | — | $0 | 31,200 | SEC↗ |
| DURAND REMY | Chief Business Officer | D To issuer | 2024-05-20 | 2024-05-20 | 31,200 | — | $0 | 0 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | D To issuer | 2024-05-20 | 2024-05-20 | 22,820 | — | $0 | 7,300 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | D To issuer | 2024-05-20 | 2024-05-20 | 7,300 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer | 2024-05-20 | 2024-05-20 | 96,000 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | D To issuer | 2024-05-20 | 2024-05-20 | 13,245 | — | $0 | 96,000 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer | 2024-05-20 | 2024-05-20 | 48,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | D To issuer | 2024-05-20 | 2024-05-20 | 296,163 | — | $0 | 48,000 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer | 2024-05-20 | 2024-05-20 | 26,761 | — | $0 | 31,200 | SEC↗ |
| Rickey James Paul | See Remarks | D To issuer | 2024-05-20 | 2024-05-20 | 31,200 | — | $0 | 0 | SEC↗ |
| CONWAY ROBERT E | Director | D To issuer | 2024-05-20 | 2024-05-20 | 50,000 | — | $0 | 0 | SEC↗ |
| Peetz Christopher | Director | D To issuer | 2024-05-20 | 2024-05-20 | 1,900 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | U Tender | 2024-05-18 | 2024-05-20 | 264,315 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | U Tender | 2024-05-18 | 2024-05-20 | 2,416,181 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | U Tender | 2024-05-18 | 2024-05-20 | 2,627,157 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | U Tender | 2024-05-18 | 2024-05-20 | 6,582,380 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | U Tender | 2024-05-18 | 2024-05-20 | 1,735,544 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | U Tender | 2024-05-18 | 2024-05-20 | 2,416,181 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | U Tender | 2024-05-18 | 2024-05-20 | 264,315 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | U Tender | 2024-05-18 | 2024-05-20 | 2,829,347 | — | $0 | 0 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 22,820 | — | $0 | 52,180 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2024-05-08 | 2024-05-10 | 13,245 | — | $0 | 336,755 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 9,845 | — | $0 | 70,155 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 10,000 | — | $0 | 0 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 38,078 | — | $0 | 26,922 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 12,365 | — | $0 | 2,635 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise deriv | 2024-05-08 | 2024-05-10 | 25,000 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 22,593 | — | $0 | 42,407 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 161,492 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 37,267 | — | $0 | 0 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 3,126 | — | $0 | 71,874 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 7,025 | — | $0 | 142,975 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 26,912 | — | $0 | 81,088 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise deriv | 2024-05-08 | 2024-05-10 | 13,377 | — | $0 | 236,623 | SEC↗ |
| FUHS ULRICH MARTIN | Chief Accounting Officer | M Exercise | 2024-05-08 | 2024-05-10 | 22,820 | $12.07 | $275.4K | 30,120 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2024-05-08 | 2024-05-10 | 13,245 | $7.55 | $100.0K | 109,245 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise | 2024-05-08 | 2024-05-10 | 10,000 | $4.76 | $47.6K | 133,392 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise | 2024-05-08 | 2024-05-10 | 9,845 | $13.20 | $130.0K | 47,949 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise | 2024-05-08 | 2024-05-10 | 12,365 | $4.09 | $50.6K | 85,314 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise | 2024-05-08 | 2024-05-10 | 25,000 | $6.51 | $162.8K | 72,949 | SEC↗ |
| DURAND REMY | Chief Business Officer | M Exercise | 2024-05-08 | 2024-05-10 | 38,078 | $3.23 | $123.0K | 123,392 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 3,126 | $6.51 | $20.4K | 82,522 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 7,025 | $13.20 | $92.7K | 79,396 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 37,267 | $0.65 | $24.2K | 119,789 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 161,492 | $0.65 | $105.0K | 281,281 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 22,593 | $11.31 | $255.5K | 303,874 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 26,912 | $3.23 | $86.9K | 330,786 | SEC↗ |
| PENG STANFORD L | See Remarks | M Exercise | 2024-05-08 | 2024-05-10 | 13,377 | $6.33 | $84.7K | 344,163 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 7,055 | — | $0 | 112,945 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 164 | — | $0 | 836 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 857 | — | $0 | 143 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 1 | — | $0 | 108,999 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 398 | — | $0 | 137 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-05-07 | 2024-05-09 | 18,286 | — | $0 | 1,214 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 7,055 | $13.20 | $93.1K | 38,256 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 1 | $7.55 | $8 | 31,201 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 857 | $6.51 | $5.6K | 39,113 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 164 | $11.31 | $1.9K | 39,277 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 18,286 | $3.23 | $59.1K | 57,563 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-05-07 | 2024-05-09 | 398 | $5.02 | $2.0K | 57,961 | SEC↗ |
| Topper James N | Director | X Exercise deriv | 2024-04-25 | 2024-04-29 | 1,200,000 | — | $0 | 0 | SEC↗ |
| Topper James N | Director | S Sale | 2024-04-25 | 2024-04-29 | 19 | $64.57 | $1.2K | 2,829,347 | SEC↗ |
| Topper James N | Director | X Exercise | 2024-04-25 | 2024-04-29 | 1,200,000 | — | $0 | 2,829,366 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-01-26 | 2024-01-29 | 44,000 | — | $0 | 1,000 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-01-26 | 2024-01-29 | 73,764 | — | $0 | 1,000 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2024-01-26 | 2024-01-29 | 73,764 | $22.31 | $1.65M | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-01-26 | 2024-01-29 | 73,764 | $6.51 | $480.2K | 73,764 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-01-26 | 2024-01-29 | 44,000 | $11.31 | $497.6K | 44,000 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2024-01-26 | 2024-01-29 | 44,000 | $25.00 | $1.10M | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2024-01-25 | 2024-01-29 | 236 | — | $0 | 74,764 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2024-01-25 | 2024-01-29 | 236 | $6.51 | $1.5K | 236 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2024-01-25 | 2024-01-29 | 236 | $22.00 | $5.2K | 0 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | X Exercise deriv | 2024-01-18 | 2024-01-22 | 1,234,636 | — | $0 | 0 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | X Exercise deriv | 2024-01-18 | 2024-01-22 | 1,234,636 | — | $0 | 0 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | X Exercise | 2024-01-18 | 2024-01-22 | 1,234,636 | $12.74 | $15.73M | 6,582,380 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | X Exercise | 2024-01-18 | 2024-01-22 | 1,234,636 | $12.74 | $15.73M | 6,582,380 | SEC↗ |
| Thompson Peter A. | Director | X Exercise deriv | 2024-01-11 | 2024-01-16 | 145,251 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | X Exercise deriv | 2024-01-11 | 2024-01-16 | 145,251 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | X Exercise | 2024-01-11 | 2024-01-16 | 145,251 | $12.74 | $1.85M | 2,416,181 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | X Exercise | 2024-01-11 | 2024-01-16 | 145,251 | $12.74 | $1.85M | 2,416,181 | SEC↗ |
| DURAND REMY | Chief Business Officer | A Award deriv | 2024-01-04 | 2024-01-05 | 78,000 | — | $0 | 78,000 | SEC↗ |
| Rickey James Paul | See Remarks | A Award deriv | 2024-01-04 | 2024-01-05 | 78,000 | — | $0 | 78,000 | SEC↗ |
| PENG STANFORD L | See Remarks | A Award deriv | 2024-01-04 | 2024-01-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | A Award deriv | 2024-01-04 | 2024-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| DURAND REMY | Chief Business Officer | A Award | 2024-01-04 | 2024-01-05 | 31,200 | — | $0 | 38,104 | SEC↗ |
| Rickey James Paul | See Remarks | A Award | 2024-01-04 | 2024-01-05 | 31,200 | — | $0 | 31,200 | SEC↗ |
| PENG STANFORD L | See Remarks | A Award | 2024-01-04 | 2024-01-05 | 48,000 | — | $0 | 72,371 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | A Award | 2024-01-04 | 2024-01-05 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Peetz Christopher | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Topper James N | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Drappa Jorn | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Hernday Natasha | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CONWAY ROBERT E | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-28 | 2023-12-29 | 1,016 | — | $0 | 247,951 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-28 | 2023-12-29 | 74,441 | — | $0 | 0 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-28 | 2023-12-29 | 3,128 | $19.82 | $62.0K | 403,481 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-28 | 2023-12-29 | 1,195,683 | $18.32 | $21.90M | 2,270,930 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-28 | 2023-12-29 | 139,166 | $18.32 | $2.55M | 264,315 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-28 | 2023-12-29 | 26,872 | $19.82 | $532.6K | 3,466,613 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-28 | 2023-12-29 | 1,195,683 | $18.32 | $21.90M | 2,270,930 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-28 | 2023-12-29 | 26,872 | $19.82 | $532.6K | 3,466,613 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-28 | 2023-12-29 | 3,128 | $19.82 | $62.0K | 403,481 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-28 | 2023-12-29 | 139,166 | $18.32 | $2.55M | 264,315 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-28 | 2023-12-29 | 1,016 | $0.65 | $660 | 1,016 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-28 | 2023-12-29 | 1,016 | $20.04 | $20.4K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | F Tax w/h | 2023-12-28 | 2023-12-29 | 48,264 | $19.65 | $948.4K | 2,627,157 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-28 | 2023-12-29 | 74,441 | $12.74 | $948.4K | 2,675,421 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-27 | 2023-12-27 | 29,573 | — | $0 | 248,967 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-27 | 2023-12-27 | 29,573 | $20.04 | $592.6K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-27 | 2023-12-27 | 29,573 | $0.65 | $19.2K | 29,573 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-27 | 2023-12-29 | 162,576 | $19.96 | $3.25M | 3,493,485 | SEC↗ |
| OrbiMed Genesis GP LLC | Director | S Sale | 2023-12-27 | 2023-12-29 | 18,922 | $19.96 | $377.7K | 406,609 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-27 | 2023-12-29 | 162,576 | $19.96 | $3.25M | 3,493,485 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2023-12-27 | 2023-12-29 | 18,922 | $19.96 | $377.7K | 406,609 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-26 | 2023-12-27 | 2,402 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-26 | 2023-12-27 | 22,084 | — | $0 | 278,540 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-26 | 2023-12-27 | 22,084 | $0.65 | $14.4K | 24,486 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-26 | 2023-12-27 | 2,402 | $0.45 | $1.1K | 2,402 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-26 | 2023-12-27 | 24,486 | $20.22 | $495.1K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-22 | 2023-12-27 | 37,825 | — | $0 | 2,402 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-22 | 2023-12-27 | 37,825 | $0.45 | $17.0K | 37,825 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-22 | 2023-12-27 | 37,825 | $20.43 | $772.8K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-19 | 2023-12-21 | 2,402 | — | $0 | 40,227 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-19 | 2023-12-21 | 15,213 | — | $0 | 535 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-19 | 2023-12-21 | 2,402 | $20.01 | $48.1K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-19 | 2023-12-21 | 2,402 | $0.45 | $1.1K | 2,402 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-19 | 2023-12-21 | 15,213 | $5.02 | $76.4K | 15,213 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-19 | 2023-12-21 | 15,213 | $19.21 | $292.2K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-18 | 2023-12-18 | 1,800 | — | $0 | 15,748 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-18 | 2023-12-18 | 1,800 | $19.00 | $34.2K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-18 | 2023-12-18 | 1,800 | $5.02 | $9.0K | 1,800 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-15 | 2023-12-18 | 45,387 | — | $0 | 17,548 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-15 | 2023-12-18 | 45,387 | $19.09 | $866.4K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-15 | 2023-12-18 | 45,387 | $5.02 | $227.8K | 45,387 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-14 | 2023-12-18 | 11,600 | — | $0 | 62,935 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-14 | 2023-12-18 | 11,600 | $5.02 | $58.2K | 11,600 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-14 | 2023-12-18 | 11,600 | $19.00 | $220.4K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise deriv | 2023-12-12 | 2023-12-12 | 8,613 | — | $0 | 42,629 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-12 | 2023-12-12 | 8,613 | $17.32 | $149.2K | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | M Exercise | 2023-12-12 | 2023-12-12 | 8,613 | $0.45 | $3.9K | 8,613 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-12 | 2023-12-12 | 32,450 | $17.32 | $562.0K | 0 | SEC↗ |
| Topper James N | Director | X Exercise deriv | 2023-12-11 | 2023-12-13 | 145,251 | — | $0 | 0 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-11 | 2023-12-12 | 68,870 | $17.26 | $1.19M | 32,450 | SEC↗ |
| Topper James N | Director | X Exercise | 2023-12-11 | 2023-12-13 | 145,251 | $12.74 | $1.85M | 1,629,366 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2023-12-08 | 2023-12-12 | 8,067 | $17.08 | $137.8K | 101,320 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-06 | 2023-12-06 | 6,446 | — | $0 | 19,500 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-06 | 2023-12-06 | 6,446 | $16.08 | $103.7K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-06 | 2023-12-06 | 6,446 | $3.23 | $20.8K | 6,446 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-05 | 2023-12-06 | 418 | — | $0 | 25,946 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-05 | 2023-12-06 | 418 | $3.23 | $1.4K | 418 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-05 | 2023-12-06 | 418 | $16.01 | $6.7K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-12-04 | 2023-12-06 | 63,947 | — | $0 | 26,364 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-12-04 | 2023-12-06 | 63,947 | $16.06 | $1.03M | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-12-04 | 2023-12-06 | 63,947 | $3.23 | $206.5K | 63,947 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-11-30 | 2023-12-01 | 700 | — | $0 | 90,311 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-11-30 | 2023-12-01 | 700 | $16.00 | $11.2K | 0 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-11-30 | 2023-12-01 | 700 | $3.23 | $2.3K | 700 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | P Buy | 2023-11-09 | 2023-11-14 | 375,000 | $12.50 | $4.69M | 1,735,544 | SEC↗ |
| Decheng Capital Global Healthc | 10% Owner | P Buy | 2023-11-09 | 2023-11-14 | 375,000 | $12.50 | $4.69M | 1,735,544 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise deriv | 2023-11-06 | 2023-11-08 | 10,989 | — | $0 | 91,011 | SEC↗ |
| Rickey James Paul | See Remarks | M Exercise | 2023-11-06 | 2023-11-08 | 10,989 | $3.23 | $35.5K | 18,003 | SEC↗ |
| Rickey James Paul | See Remarks | S Sale | 2023-11-06 | 2023-11-08 | 18,003 | $16.03 | $288.6K | 0 | SEC↗ |
| Dummer Wolfgang | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sandler Andrew Seth | Chief Medical Officer | A Award deriv | 2023-01-05 | 2023-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PENG STANFORD L | See Remarks | A Award deriv | 2023-01-04 | 2023-01-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Rickey James Paul | See Remarks | A Award deriv | 2023-01-04 | 2023-01-05 | 109,000 | — | $0 | 109,000 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | A Award deriv | 2023-01-04 | 2023-01-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CONWAY ROBERT E | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Peetz Christopher | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Hernday Natasha | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Drappa Jorn | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Topper James N | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | A Award | 2022-09-23 | 2022-09-27 | 1,360,544 | $7.35 | $10.00M | 1,360,544 | SEC↗ |
| Decheng Capital China Life Sci | 10% Owner | A Award | 2022-09-23 | 2022-09-27 | 639,456 | $7.35 | $4.70M | 5,347,744 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | A Award | 2022-09-23 | 2022-09-27 | 639,456 | $7.35 | $4.70M | 5,347,744 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | A Award | 2022-09-23 | 2022-09-27 | 1,360,544 | $7.35 | $10.00M | 1,360,544 | SEC↗ |
| Sandler Andrew Seth | Chief Medical Officer | A Award deriv | 2022-08-17 | 2022-08-18 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Drappa Jorn | Director | A Award deriv | 2022-07-18 | 2022-07-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Venkatesan Jay | Director, 10% Owner | M Exercise deriv | 2022-07-15 | 2022-07-19 | 20,063 | $0.45 | $9.0K | 70,000 | SEC↗ |
| Venkatesan Jay | Director, 10% Owner | M Exercise | 2022-07-15 | 2022-07-19 | 20,063 | $0.45 | $9.0K | 238,126 | SEC↗ |
| FHM LIFE SCIENCES VIII, L.P. | 10% Owner | P Buy | 2022-02-11 | 2022-02-15 | 112,665 | $7.10 | $799.9K | 1,484,115 | SEC↗ |
| Rickey James Paul | Senior VP and CFO | A Award deriv | 2022-01-04 | 2022-01-06 | 112,500 | — | $0 | 112,500 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | A Award deriv | 2022-01-04 | 2022-01-06 | 215,000 | — | $0 | 215,000 | SEC↗ |
| PENG STANFORD L | See Remarks | A Award deriv | 2022-01-04 | 2022-01-06 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Hernday Natasha | Director | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CONWAY ROBERT E | Director | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Peetz Christopher | Director | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Venkatesan Jay | Director, 10% Owner | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rickey James Paul | Senior VP and CFO | S Sale | 2021-12-31 | 2022-01-04 | 17,013 | $13.92 | $236.8K | 7,014 | SEC↗ |
| Peetz Christopher | Director | S Sale | 2021-09-23 | 2021-09-24 | 1,900 | $10.17 | $19.3K | 1,900 | SEC↗ |
| CONWAY ROBERT E | Director | S Sale | 2021-09-23 | 2021-09-24 | 15,000 | $10.08 | $151.2K | 50,000 | SEC↗ |
| CONWAY ROBERT E | Director | P Buy | 2021-09-23 | 2021-09-27 | 15,000 | $10.08 | $151.2K | 50,000 | SEC↗ |
| Peetz Christopher | Director | P Buy | 2021-09-23 | 2021-09-27 | 1,900 | $10.17 | $19.3K | 1,900 | SEC↗ |
| CONWAY ROBERT E | Director | P Buy | 2021-09-21 | 2021-09-23 | 10,000 | $9.80 | $98.0K | 35,000 | SEC↗ |
| Topper James N | Director, 10% Owner | A Award deriv | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| Topper James N | Director, 10% Owner | D To issuer | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,371,450 | SEC↗ |
| Cui Xiangmin | Director, 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 1,542,553 | $9.40 | $14.50M | 4,708,288 | SEC↗ |
| Venkatesan Jay | Director, 10% Owner | S Sale | 2021-09-17 | 2021-09-21 | 400,000 | $9.40 | $3.76M | 2,600,980 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-09-17 | 2021-09-21 | 45,262 | $10.01 | $453.1K | 109,387 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-09-17 | 2021-09-21 | 400,000 | $9.40 | $3.76M | 2,600,980 | SEC↗ |
| Alpine Bioventures, GP, LLC | 10% Owner | S Sale | 2021-09-17 | 2021-09-21 | 400,000 | $9.40 | $3.76M | 2,600,980 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 425,531 | $9.40 | $4.00M | 425,531 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 585,106 | $9.40 | $5.50M | 3,656,061 | SEC↗ |
| Decheng Capital Management III | 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 1,542,553 | $9.40 | $14.50M | 4,708,288 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 585,106 | $9.40 | $5.50M | 3,656,061 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 425,531 | $9.40 | $4.00M | 425,531 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-09-16 | 2021-09-17 | 6,768 | $10.00 | $67.7K | 154,649 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-09-15 | 2021-09-17 | 3,484 | $10.00 | $34.8K | 161,417 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-06-28 | 2021-06-29 | 3,479 | $10.00 | $34.8K | 164,901 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-06-25 | 2021-06-29 | 9,473 | $10.01 | $94.8K | 168,380 | SEC↗ |
| Goldberg Zelanna | Chief Medical Officer | A Award deriv | 2021-06-01 | 2021-06-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-05-20 | 2021-05-21 | 1,221 | $15.00 | $18.3K | 177,853 | SEC↗ |
| GOLD MITCHELL | Executive Chairman and CEO | S Sale | 2021-05-19 | 2021-05-21 | 50,965 | $15.03 | $766.0K | 179,074 | SEC↗ |